NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Call
23 Outubro 2023 - 12:13PM
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to
issue its Q3 2023 business and financial highlights before the
opening of the market on October 26, 2023. The Company will host a
conference call at 8:00 a.m., Eastern Time on October 26, 2023.
For participants who wish to access the Q3 2023
Conference Call live via telephone and be able to ask questions,
please register in advance here. Upon registering, a dial-in and
unique PIN will be provided on screen and via email to join the
call. An audio-only webcast of the call, along with the earnings
press release and accompanying condensed financial statements, may
be accessed in the Investors section of the Company’s website at
www.NeuroMetrix.com. Following the conference call, a replay of the
call will be available for one year on the Company's Investors
section of the website.
About NeuroMetrix
NeuroMetrix is a commercial stage healthcare
company that develops and commercializes neurotechnology devices to
address unmet needs in the chronic pain and diabetes markets. The
Company's products are wearable or hand-held medical devices
enabled by proprietary consumables and software solutions that
include mobile apps, enterprise software and cloud-based systems.
The Company has two commercial brands. Quell® is a wearable
neuromodulation platform. DPNCheck® is a point-of-care screening
test for peripheral neuropathy. For more information, visit
www.NeuroMetrix.com.
NeuroMetrix, Inc.Thomas T. HigginsSVP and Chief
Financial Officerneurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
NeuroMetrix (NASDAQ:NURO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
NeuroMetrix (NASDAQ:NURO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024